SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001521536-11-000289
Filing Date
2011-09-27
Accepted
2011-09-27 16:22:38
Documents
5
Period of Report
2011-09-22
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 q1100178_8k-biozone.htm 8-K 30410
2 FORM OF SECURITIES PURCHASE AGREEMENT q1100178_ex10-1.htm EX-10.1 144631
3 FORM OF CONVERTIBLE PROMISSORY NOTE q1100178_ex10-2.htm EX-10.2 32334
4 FORM OF WARRANT q1100178_ex10-3.htm EX-10.3 123939
5 FORM OF REGISTRATION RIGHTS AGREEMENT q1100178_ex10-4.htm EX-10.4 112526
  Complete submission text file 0001521536-11-000289.txt   445210
Mailing Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 850 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 111109847
SIC: 2834 Pharmaceutical Preparations